+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Traveller's Diarrhoea Treatment Market Report and Forecast 2023-2031

  • PDF Icon


  • 160 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5805714
The global traveller’s diarrhoea treatment market size is likely to be driven by the increasing demand for natural and clean label ingredients across the globe. The market value is anticipated to grow at a CAGR of 6% during the forecast period of 2023-2031.

Traveller’s Diarrhoea: Introduction

Traveller's diarrhoea is a common health concern for individuals traveling to different regions and countries. It is characterized by the onset of loose and frequent bowel movements, often accompanied by abdominal cramps, nausea, and vomiting. The condition is primarily caused by consuming contaminated food or water, typically due to bacterial, viral, or parasitic infections.

Key Trends in the Traveller’s Diarrhoea Treatment Market

Some key trends involved in the traveller’s diarrhoea treatment market are as follows:
  • Increasing Travel Activity: The rise in global travel and tourism has contributed to a higher incidence of traveller's diarrhoea. As more people travel to various destinations, especially to regions with different hygiene and sanitation standards, the risk of exposure to contaminated food and water increases
  • Focus on Prevention: There is a growing emphasis on preventive measures to reduce the risk of traveller's diarrhoea. This includes educating travelers about safe food and water practices, promoting proper hygiene, and encouraging the use of water purification methods and food hygiene practices
  • Improved Diagnostics: Diagnostic methods for traveller's diarrhoea have seen advancements in recent years. Rapid diagnostic tests are becoming more accessible, allowing for quick identification of the causative pathogens. These tests aid in targeted treatment and appropriate management of the condition

Traveller’s Diarrhoea Treatment Market Segmentations

Market Breakup by Drug Type

  • Oral Rehydration Therapy (ORS)

Antidiarrhoeal Agents

  • Antibiotics
  • Azithromycin
  • Ciprofloxacin
  • Quinolones
  • Rifaximin
  • Others


  • Others

Market Breakup by Pathogen

  • Bacteria
  • Viruses
  • Protozoa
  • Others

Market Breakup by Age

  • Adult
  • Children

Market by Route of Administration

  • Oral
  • Parenteral

Market by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Traveller’s Diarrhoea Treatment Market Scenario

The market for traveller's diarrhoea management and prevention is driven by the increasing global travel activity and the rising awareness of health risks associated with travelling to different regions. Traveller's diarrhoea is a common concern for both leisure and business travelers, and the market offers various products and services to address this issue.

The market is composed of several key players, including pharmaceutical companies, travel health clinics, healthcare providers, and manufacturers of diagnostic tests, medications, and preventive measures. These entities play a crucial role in providing solutions and guidance to travelers to minimize the risk of traveller's diarrhoea.

The market is driven by the increasing demand for travel health services, as travelers prioritize their health and seek professional guidance for a safe and healthy travel experience. Travel clinics, healthcare providers, and online platforms have expanded their services to cater to this growing demand, offering comprehensive solutions and personalized recommendations.

Overall, the market for traveller's diarrhoea management and prevention is dynamic and evolving, driven by increasing travel activity and the need for safe and healthy travel experiences. The market offers a range of products and services to address the specific needs of travelers, with a focus on prevention, treatment, and digital health solutions.

Traveller’s Diarrhoea Treatment Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Bausch Health Companies Inc
  • COSMO Pharmaceuticals
  • Immuron Ltd
  • Sanofi SA
  • Bayer AG
  • Merck & Co., Inc
  • Johnson & Johnson Services, Inc
  • Novartis AG
  • Basilea Pharmaceutica Ltd
  • Eli Lilly and Company

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Traveller’s Diarrhoea Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Traveller’s Diarrhoea Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Traveller’s Diarrhoea Epidemiology (2016-2031)
5.3 Europe Traveller’s Diarrhoea Epidemiology (2016-2031)
5.4 Asia-Pacific Traveller’s Diarrhoea Epidemiology (2016-2031)
5.5 Latin America Traveller’s Diarrhoea Epidemiology (2016-2031)
5.6 Middle East & Africa Traveller’s Diarrhoea Epidemiology (2016-2031)
6 Global Traveller’s Diarrhoea Treatment Market Overview
6.1 Global Traveller’s Diarrhoea Treatment Market Historical Value (2016-2022)
6.2 Global Traveller’s Diarrhoea Treatment Market Forecast Value (2023-2031)
7 Global Traveller’s Diarrhoea Treatment Market Landscape
7.1 Traveller’s Diarrhoea Treatment: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Traveller’s Diarrhoea Treatment: Product Landscape
7.2.1 Analysis by Drug Type
7.2.2 Analysis by Pathogen
7.2.3 Analysis by Age
7.2.4 Analysis by Route of Administration
7.2.5 Analysis by Distribution Channel
8 Traveller’s Diarrhoea Treatment Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Traveller’s Diarrhoea Treatment Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Traveller’s Diarrhoea Treatment Market Segmentation
11.1 Global Traveller’s Diarrhoea Treatment Market by Drug Type
11.1.1 Market Overview
11.1.2 Oral Rehydration Therapy (ORS)
11.1.3 Antidiarrhoeal Agents Antibiotics Azithromycin Ciprofloxacin Quinolones Rifaximin Others
11.1.4 Vaccine/Prophylactics
11.1.5 Others
11.2 Global Traveller’s Diarrhoea Treatment Market by Pathogen
11.2.1 Market Overview
11.2.2 Bacteria
11.2.3 Viruses
11.2.4 Protozoa
11.2.5 Others
11.3 Global Traveller’s Diarrhoea Treatment Market by Age
11.3.1 Market Overview
11.3.2 Adult
11.3.3 Children
11.4 Global Traveller’s Diarrhoea Treatment Market by Route of Administration
11.4.1 Market Overview
11.4.2 Oral
11.4.3 Parenteral
11.5 Global Traveller’s Diarrhoea Treatment Market by Distribution Channel
11.5.1 Market Overview
11.5.2 Hospital Pharmacies
11.5.3 Retail Pharmacies
11.5.4 Online Pharmacies
11.5.5 Others
11.6 Global Traveller’s Diarrhoea Treatment Market by Region
11.6.1 Market Overview
11.6.2 North America
11.6.3 Europe
11.6.4 Asia Pacific
11.6.5 Latin America
11.6.6 Middle East and Africa
12 North America Traveller’s Diarrhoea Treatment Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Traveller’s Diarrhoea Treatment Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Traveller’s Diarrhoea Treatment Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Traveller’s Diarrhoea Treatment Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Traveller’s Diarrhoea Treatment Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Partnership and Collaborations Analysis
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 Bausch Health Companies Inc.
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 COSMO Pharmaceuticals
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Immuron Ltd.
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 Sanofi SA
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 Bayer AG
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 Merck & Co., Inc
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 Johnson & Johnson Services, Inc.
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Novartis AG
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Basilea Pharmaceutica Ltd
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 Eli Lilly and Company
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
24 Traveller’s Diarrhoea Treatment - Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket

Companies Mentioned

  • Bausch Health Companies Inc.
  • COSMO Pharmaceuticals
  • Immuron Ltd.
  • Sanofi SA
  • Bayer AG
  • Merck & Co. Inc
  • Johnson & Johnson Services Inc.
  • Novartis AG
  • Basilea Pharmaceutica Ltd
  • Eli Lilly and Company